Wolters Kluwer Health has announced strong results for the Lippincott portfolio of journals in the 2022 Journal Impact Factor (JIF), the journal metric released annually by Clarivate Analytics as part of the Journal Citation Reports (JCR). Against an industry backdrop of declining JIFs, Lippincott’s performance in the latest rankings showed consistent year-over-year improvements. The annual rankings evaluate over 21,500 high-quality academic journals from more than 250 scientific and research disciplines.
The 2023 rankings featured 387 Wolters Kluwer journals, with more than half (52%) receiving improved rankings from the previous year and an overall net increase for the portfolio. Impressively, three Lippincott titles came in at #1 in their respective categories, Academic Medicine, Circulation and Ear and Hearing.
Despite the recent decline in the output across scientific publishing, Lippincott journals maintained its overall rank, and in some cases even improved their rankings. For categories such as Anesthesiology, Cardiac and Cardiovascular Systems, Obstetrics and Gynecology, Peripheral Vascular Disease, and Transplantation, Lippincott publishes multiple journals that were recognized in the Top 10.
While the 2023 analytics showcase Wolters Kluwer’s long-time prominence in academic research, new additions to the publishing lineup were also included. In fact, 164 newer Lippincott journals were included in the Emerging Sources Citation Index (ESCI), where the titles received JIFs for the first time.
Click here to read the original press release.
